100+ Total results for product and free and sample content found
Scrip
By Jessica Merrill 14 Nov 2022
The pandemic phase will last through late 2021/early 2022, becoming a more seasonal opportunity for several years after, Pfizer management predicted during the company's second quarter call.
Pharma Intelligence Apps
06 Jan 2022
London, 04.01.22 – Pharmaceutical companies must keep improving COVID-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, the world’s leading intelligence provider for the biopharma industry.
Topic Coronavirus
Biomedtracker, Datamonitor Healthcare
21 Sep 2021
Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.
Topic Drug Review Coronavirus
By Karen Currie 03 Jun 2021
The goal of our second Clinical Trials & the COVID-19 Vaccine Pulse Report is to uncover who is still hesitant to take a vaccine, and what public health experts from pharma to the U.S. government can do to turn the tide.
Topic Coronavirus Clinical Trials
Trialtrove
20 May 2021
Over the past five years, our analysis of completed trials consistently observed growth trends.
Topic Coronavirus Clinical Trials
16 Apr 2021
Learn about the latest trends affecting biopharma R&D including, study diversity & transparency, predictive feasibility and more...
Scrip
By Alaric DeArment 31 Dec 2020
Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.
Topic Coronavirus
Generics Bulletin
By David Wallace 08 Dec 2020
Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged
Topic Coronavirus EU Policy & Regulation
Pink Sheet
By Derrick Gingery 08 Dec 2020
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: